Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
propionyl l-carnitine (1 trial)
Intermittent Claudication (Phase 3)
Peripheral Arterial Disease (Phase 3)
Peripheral Vascular Diseases (Phase 3)
Vascular Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)